Skip to main content
  • Login
Home

User menu

Mega menu

  • EASL
  • Resources

    Resources

    • EASL Resources
      • All Resources
      • Basic Techniques in Experimental Hepatology at a Glance
      • Clinical Practice Guidelines
      • Congress Resources
      • COVID-19 Resources
      • EASL Molecular Tumour Boards
      • EASL Policy Dialogues
      • EASL Quiz
      • ePosters
      • EASL DeepDive
      • EASL Journal Club
      • Nurses and AHPs
      • Online Courses
      • On-demand Webinars
      • Podcasts
      • Slide Decks
      • Webcasts
      • Webinars Calendar
    • EASL-Related Resources
      • EHC On-demand Webinar
      • ERN Rare-Liver On-demand Webinars
      • Baveno VII - Consensus Workshop
      • Baveno VII - Pediatric Research Workshop
    • Industry Resources
      • All Resources
      • Industry Symposia - EASL Monothematic Conference 2023
      • Industry Symposia - International Liver Congress
      • Industry Symposia - Liver Cancer Summit
      • Industry Symposia - NAFLD Summit 2022
      • GSK Resources
    • Patient Resources
      • All Resources
      • COVID-19 Resources
      • Documents
      • ePosters
      • Infographics
      • Patient Guidelines
      • Podcasts
      • Slide Decks
      • Takeaways
      • Webcasts
  • EASL Studio
  • EASL Campus Connect
    • My Community
    • Explore Community
      • EASL Community Feed
      • All Topics
      • Community FAQ's
    • Create
  • Our Sponsors

EASL Community Feed

Get the latest news from the EASL Community

Newest topics

Hepatitis C Point of Care Testing
Gavin Hooper-Newton · 6 Feb
Welcome to EASL Campus Connect!
Elinam Gayi · 20 Jun
All topics

  • Anonymous created an event

    9 months ago

    EASL DeepDive: Addressing unmet needs and defining valuable endpoints

    Total amount of likes 0
    Total amount of comments 0
    Read more about EASL DeepDive: Addressing unmet needs and defining valuable endpoints
    Log in to post comments

  • tomasz07 tomasz07 commented on ERN Rare-Liver on-demand Webinar…

    9 months ago
    ERN Rare-Liver on-demand Webinar: Alpha-1 antitrypsin deficiency: A poster child for nucleic acid therapy

    ERN Rare-Liver on-demand Webinar: Alpha-1 antitrypsin deficiency: A poster child for nucleic acid therapy

    Description In this ERN Rare-Liver webinar, held on 12 December 2023, Prof. Strnad and Dr Ruiz gave an exciting update to the alpha-1 antitrypsin deficiency. The presentation covered “siRNA therapy in hepatology: a1-AT deficiency”. Targeted Audience General practitioners Hepatologists Oncologists Health care professi...
    Total amount of likes 0
    Total amount of comments 1
    Read more about ERN Rare-Liver on-demand Webinar: Alpha-1 antitrypsin deficiency: A poster child for nucleic acid therapy
    Log in to post comments
    tomasz07 tomasz07
    tomasz07 tomasz07 • 9 months ago

    test

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Anonymous created an event

    10 months ago

  • Robert Kilpatrick created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Robert Kilpatrick created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Anonymous created an event

    1 year ago

  • Christian Molina-Aguilar posted

    1 year ago

  • Margaret Vernon commented on EASL Studio - Deciphering the dr…

    1 year ago

    EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)

    EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention   Debbie Shawcross (Moderator), Paolo Angeli (Faculty), Salvador Augustin (Boehringer Ingelheim representative), Paolo Caraceni (CSL Behring representative) This EASL Studio is supported by Boehr...
    Total amount of likes 0
    Total amount of comments 2
    Read more about EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)
    Log in to post comments
    Margaret Vernon
    Margaret Vernon • 1 year ago

    Excellent discussion - very informative - thank you

    Like
    1 like
    Dislike 0
    Reply
    Anonymous
    Margaret Vernon
    Margaret Vernon • 1 year ago

    Excellent discussion - very informative - thank you

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Anonymous created an event

    1 year ago

  • Luis Rodriguez commented on TIPS and ascites (Complete Sessi…

    1 year ago

  • Anonymous created an event

    1 year ago

  • ABU SALEH MD SADEQUL ISLAM commented on Non-alcoholic fatty liver diseas…

    1 year ago
    Non-alcoholic fatty liver disease: A patient guideline

    Non-alcoholic fatty liver disease: A patient guideline

    This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which ha...
    Total amount of likes 2
    Total amount of comments 1
    ABU SALEH MD S… • 1 year ago

    EASY LANGUAGE

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

    • Pagination

    • Previous page ‹‹
    • Next page ››

Community Stream

Easl Community FeedMy Feed
Browse Stream
EASL.EU Home
Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland

Follow us:

Sign up to EASL News

©2019 - EASL. All Rights Reserved. Powered by Enovation.

Footer menu

  • Privacy Policy
  • Cookie Policy